The research activity is aimed at the development and validation of chromatographic methods for the qualitative and quantitative determination of biologically active molecules in human and animal, cosmetics, food, and environmental complex matrices. These procedures have been applied to different analytes and drugs/drug associations also finding application in clinical and pre-clinical studies, to characterize new delivery systems of the active principle to improve their pharmacological properties. In the development of the method are applied predictive models and chemometric both for the optimization of extraction protocols and for final data processing. Particular attention is given to the innovative (micro)extraction techniques and new instrumental configurations for complex matrix quantitative analysis. Scientific activity is proven by more than 238 publications in International peer-reviewed Journals, by 18 book chapters and 7 books, by more than 30 oral and 160 poster communications at National and International conferences.

He is Editor-In-Chief of “Anti-Cancer Agents in Medicinal Chemistry” (Bentham Science Publishers, Q3 in Chemistry, Medicinal) (19/11/2020).
He is Co-Editor of Current Medicinal Chemistry (Bentham Science Publishers, Q2 in Chemistry, Medicinal) (01/3/2021).
He is Co-editor-in-chief of “Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry” (Bentham Science Publishers) (24/5/2016).
He was involved as a Section Editor for “Current Enzyme Inhibition” (Bentham Science Publishers) (01/09/2020-14/06/2021).
He is also a member of the Editorial Board of “Journal of Enzyme Inhibition and Medicinal Chemistry” (Taylor & Francis, Q1 in Chemistry, Medicinal), “Antioxidants” (MDPI, Q1 in Chemistry, Medicinal), “Expert Opinion on Therapeutic Patents” (Taylor & Francis, Q1 in Chemistry, Medicinal), “Bioorganic Chemistry” (Elsevier, Q1 in Chemistry, Organic, Q1 in Biochemistry & Molecular Biology), “Mini-Reviews in Medicinal Chemistry” (Bentham Science Publishers, Q2 in Chemistry, Medicinal), “Antibiotics” (MDPI, Q1 in Pharmacology & Pharmacy, Q2 in Infectious Diseases), “CNS & Neurological Disorders – Drug Targets” (Bentham Science Publishers, Q3 in Pharmacology & Pharmacy, Q3 in Neurosciences) and Scientifica (Hindawi).
He was appointed as Review Editor in Frontiers in Oncology (Section “Cancer Molecular Targets and Therapeutics”, 27/06/21) and in Frontiers in Drug Safety and Regulation (Section “Substance-Based Medical Devices” 31/10/21).
Guest Associate Editor in “Medicinal and Pharmaceutical Chemistry” and Review Editor in “Cancer Molecular Targets and Therapeutics”, “Ethnopharmacology” and “Substance-Based Medical Device” for Frontiers Publisher.